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Zusammenfassung
Ein neues Messprinzip in der LC-MS/MS (Flüssigchromatographie mit
Massenspektrometrie) wird zur Bestimmung der Immunsuppressiva
Sirolimus,Everolimus,TacrolimusundCyclosporinAvorgestellt.Hierbei
wird das Cs
+-Ion als Produkt-Ion im MRM (multiple reaction monitoring)
Modus gemessen. Eine chromatographische Trennung der Immunsup-
pressiva wurde mit einer Phenyl-Hexyl-RP Säule erzielt. Die Elution er-
folgteunterVerwendungeinesternärenGradientenausWasser,Metha-
nol und Acetonitril mit 0,1% v/v Ameisensäure und 0,1 mmol/l Cs
+. Für
die Quantifizierung wurden Cyclosporin D, Ascomycin und 32-Desme-
thoxy-Rapamycineingesetzt.DieWiederholpräzisionderneuenMethode
hat einen Varianzkoeffizienten (VK) von 2,57% für Sirolimus, 2,11% für
Everolimus, 2,31% für Tacrolimus und 2,11% für Cyclosporin A.
Schlüsselwörter: Immunosuppressiva, LC-MS/MS, Cs+-Addukte
Introduction
The therapeutic drug monitoring (TDM) of immunosup-
pressive drugs in blood of organ-transplanted patients is
of utmost importance to prevent intoxication or rejection
due to incorrect dosage. Commonly used immunosup-
pressive agents are calcineurin inhibitors such as
cyclosporin A and tacrolimus or the mTOR inhibitors si-
rolimus and everolimus. Recently a new therapeutic
strategyhasbeentocombineimmunosuppressivedrugs
with different mechanisms of action in order to reduce
undesirable side effects. This often leads to a lowering
of the therapeutic concentrations of these drugs. Analyt-
ical problems occur in the detection of clinically relevant
low levels of immunosuppressive agents, which in turn
requiresamoresensitiveanalyticalmeasurementproced-
ure at low analyte concentrations for all the drugs used.
Several LC-MS/MS methods for routine measurement of
immunosuppressive drugs in whole blood have been de-
scribed [1], [2], [3]. These routine methods have been
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turnaround time. Methods without chromatographic
separation of the analytes require cycles of only a few
minutes per sample. Unfortunately, co-elution of the
compounds usually leads to a bias in the analytical re-
sults, due to a lack of specificity of the mass transition
in the MRM mode of the LC-MS/MS measurements [4],
[5]. Avoidance of this phenomenon requires separation
anddetectionoftheparentsubstancesfromthedifferent
metabolites with biological activity.
LC-MS/MS procedures for determination of serum levels
of digoxin and digitoxin have been recently published
from this laboratory [6], [7] using Cs
+ adduct formation,
which allows potential improvement of both analytical
sensitivity and specificity.
The aim of the present study was to develop a method
for determination of immunosuppressive agents, by util-
ising the principle of measurement of Cs
+ adducts, thus
forming the basis of a reliable method for defining target
values for immunosuppressive drugs in external quality
assessment schemes (EQAS).
ThisarticledescribesaLC-MS/MSmethodwithcomplete
chromatographic separation of the immunosuppressive
drugs cyclosporin A (cyclosporin A, Sandimmune
®), tac-
rolimus (FK-506, Prograf
®), sirolimus (rapamycin,
Rapamune
®)andeverolimus(Certican
®),withcyclosporin
D, ascomycin and 32-desmethoxy-rapamycin as internal
standards.
Materials and methods
Chemicals
Rapamycin (>99%), tacrolimus (FK-506, >99%) and cyc-
losporin A (>99%) were obtained from LC Laboratories,
Woburn, MA, USA. Cyclosporin D and everolimus were a
kind gift from Recipe, München, Germany. 32-desmeth-
oxy-rapamycinwasakinddonationfromWyatt,St.Davids,
PA, USA. Ascomycin, formic acid (98%, puriss. p.a.) and
cesium hydroxide (purity 99.97%), were purchased from
Sigma-Aldrich, Taufkirchen, Germany. Methanol (LiChro-
solv) was obtained from Merck, Darmstadt, Germany.
Water was prepared using the purification system
Direct-Q™ 5 (Millipore GmbH, Eschborn, Germany).
Apparatus
The HPLC system used was from Shimadzu (Duisburg,
Germany)consistingofaSCL-10Asystemcontroller,three
LC-10ADvp pumps (A, B, C), a DGU-14A degasser; a SIL-
10AD autoinjector; a CTU-10AS column oven; and a FCU-
12A Flow Switch (rotary valve).
TheMassSpectrometerwasa4000QTrapequippedwith
a TurboV
TM ESI source with Turboion Spray
TM probe from
Applied Biosystems (MDS-Sciex, Darmstadt, Germany).
HPLC-MS/MS measurement conditions
The chromatographic separation was performed on a
phenyl-hexyl-RP column (Luna
®, 2 x 150 mm, 5 µm, Phe-
nomenex, Aschaffenburg, Germany).
A ternary gradient was used for elution consisting of elu-
ent A (pump A): 0.1% v/v HCOOH in water + 0.1 mmol/l
CsOOCH;eluentB(pumpB):0.1%v/vHCOOHinmethanol
+ 0.1 mmol/l CsOOCH and eluent C (pump C): 0.1% v/v
HCOOH in CH3CN + 0.1 mmol/l CsOOCH. CsOOCH was
produced by neutralising CsOH with HCOOH to pH 7. The
flow rate was 300 µl/min. The column temperature was
set at 50°C. In order to avoid contamination of the ESI
sourceaswitchingvalvesystem(rotaryvalveA)wasintro-
duced.Atposition0ofrotaryvalveAtheeluateispassed
into the ESI source. At position 1 the eluate is directed
into waste (Figure 1, Table 1).
Table 1: Gradient profile for HPLC separation in detail
TheMSdetectionwasperformedinthepositiveionmode.
The mass transitions (m/z) for MS detection are given in
Table 2. The m/z of 132.9 amu is the mass of the Cs
+
ion.
Table 2: Mass transitions of the four immunosuppressive
agents tacrolimus, sirolimus, everolimus and cyclosporin A
and the internal standards ascomycin, 32-desmethoxy-
rapamycin and cyclosporin D
The settings of the mass spectrometer are given in Table
3.(Theabbreviationsforsettingsarespecifictothe4000
Q TRAP software used to control the system.)
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 1: Gradient profile for HPLC separation (% of eluent B in green, % of eluent C in blue)
Table 3: Instrument settings in the 4000 Q TRAP for MRM
mode
Results
As shown in previous publications [6], [7] the generation
ofCs
+ionadductscombinedwithLC-MS/MSofferedgreat
advantages in analysis of digoxin and digitoxin, both in
SIMandinMRMmode.Itwasobserved,thatintheMRM
mode,theCs
+adductasparentiondecomposesinaway
that the Cs
+ ion becomes detectable as product ion.
This principle of measurement was investigated for the
immunosuppressive agents tacrolimus, sirolimus, evero-
limus,cyclosporinAtogetherwiththeanaloguesascomy-
cin, 32-desmethoxy-rapamycin and cyclosporin D used
as internal standards.
ThegenerationofCs
+adductsisexamplifiedforcyclospo-
rin A in Figure 2. The Q1 scan was performed by using a
standardsolution,dissolvedineluentB,whichcontained
0.1 mM Cs
+. Under these conditions the singly charged
Cs
+ adduct generates the major signal (1335 amu). Only
small amounds of the protonated form (1203 amu), the
Na
+ adduct (1225 amu) and the K
+ adduct (1241 amu)
are visible. Na
+ and K
+ probably originate from the manu-
facturing procedure and can be separated by HPLC.
Fragmentation of the cyclosporin A Cs
+ adduct was stud-
ied using an 4000 Q TRAP in the enhanced product ion
scan mode (Figure 3). The ion trap option offers a high
mass resolution. In the product ion scan of Cs
+ adduct of
cyclosporinAwithaparentmassof1335 amu,themass
of 132.9 amu is the main signal. The isotope pattern of
thissignalandthedefinedmassindicatesthatthissignal
originates solely from Cs
+.
During the mass transition the mass of 1202 amu is lost
(Figure 4). This value corresponds to the mass of the
unprotonated cyclosporin A molecule. Thus, it can be
considered, that cyclosporin A is split off in form of a
neutral molecule in the fragmentation process. This
concept is supported by the results of the neutral loss
scan.Thisscandemonstrates,thattheonlysourceofthe
neutral loss of the unprotonated cyclosporin A molecule
is the Cs
+ adduct of cyclosporin A with the mass of 1235
amu.
The adduct formation with Cs
+ and the subsequent colli-
sioninduceddissociationwithCs
+astheproductionwas
observedforallsevenanalytes.Thisprincipleofdetection
was used for the development of the chromatographic
separation of all immunosuppressive drugs. A baseline
separationwasrealizedbyusingaternarygradient(Figure
5).
In Figures 6-12 chromatograms of standard solutions of
tacrolimus (Figure 6), sirolimus (Figure 7), everolimus
(Figure 8), cyclosporin A (Figure 9) and the analogues
cyclosporin D (Figure 10), ascomycin (Figure 11) and 32-
desmethoxy-rapamycin(Figure12)areshowninseparate
runs. In addition to the declared components, these
standardsolutionscontainadditionalsubstances(Figures
6-10), which are separated during the chromatographic
procedure. Tacrolimus, sirolimus, everolimus, ascomycin
and32-desmethoxy-rapamycincontainisobariccompon-
ents, which probably represent isomers, as has been
described elsewhere [8]. For the cyclosporins A and D
cross contamination is observed (Figures 11-12). Cyc-
losporinAcontainsabout5%cyclosporinDandcyclospor-
in D contains about 1% cyclosporin A. This is of import-
ance, as cyclosporin D is used as internal standard for
quantification of cyclosporin A.
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 2: Q1 scan of a cyclosporin A standard solution (1 µg/ml in eluent B) infused at a flow rate of 10 µl/min
Figure 3: Enhanced product ion scan of a cyclosporin A standard solution (1 µg/ml in eluent B) infused at a flow rate of
10 µl/min
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 4: Neutral loss scan of mass 1202 amu (1 µg/ml in eluent B) infused at a flow rate of 10 µl/min
Figure 5: HPLC-MS/MS chromatogram (overlaid graphs of single mass traces) of a standard mixture of tacrolimus (8.59 min),
sirolimus(11.59min),everolimus(12.70min),cyclosporinA(24.12min)andcyclosporinD(27.16min),10µl(1µg/ml)injected
(for details see Table 1, Figure1)
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 6: HPLC-MS/MS chromatogram (overlaid graphs of mass traces defined in Table 2) of a tacrolimus standard solution,
10 µl (1 µg/ml)
Figure 7: HPLC-MS/MS chromatogram (overlaid graphs of mass traces defined in Table 2) of a sirolimus standard solution,
10 µl (1 µg/ml)
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 8: HPLC-MS/MS chromatogram (overlaid graphs of mass traces defined in Table 2) of an everolimus standard solution,
10 µl (1 µg/ml)
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 9: HPLC-MS/MS chromatogram of a cyclosporin A standard solution, 10 µl (1 µg/ml)
upper panel: overlaid graphs of mass traces defined in Table 2
lower panel: extracted mass trace of cyclosporin D
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 10: HPLC-MS/MS chromatogram of a cyclosporin D standard solution, 10 µl (1 µg/ml)
upper panel: overlaid graphs of mass traces defined in Table 2
lower panel: extracted mass trace of cyclosporin A
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Figure 11: HPLC-MS/MS chromatogram (overlaid graphs of mass traces defined in Table 2) of a ascomycin standard solution,
10 µl (1 µg/ml)
Figure 12: HPLC-MS/MS chromatogram (overlaid graphs of mass traces defined in Table 2) of a 32-desmethoxy-rapamycin
standard solution, 10 µl (1 µg/ml)
For quantification of tacrolimus, ascomycin was used as
internalstandard,forsirolimusandeverolimustheintern-
al standard used was 32-desmethoxy-rapamycin.
The validity of this method was tested during the course
of this study, in which the inter-run precision was meas-
ured using standard solutions. The precision measured
– expressed as the coefficient of variation (CV) - under
these conditions was 2.57% for sirolimus, 2.11% for
everolimus,2.31%fortacrolimusand2.11%forcyclospo-
rin A (Table 4).
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Kaiser et al.: A new approach for the determination of immunosuppressive ...Table 4: Inter run precision of a standard mixture of tacrolimus, sirolimus, everolimus, cyclosporin A, cyclosporin D, ascomycin
and 32-desmethoxy-rapamycin
Discussion
RecentLC-MS/MSmeasurementsofimmunosuppressive
drugs have often used NH4
+ adducts, which give rise to
several different product ions [4]. Addition of Cs
+ ions
reducedthenumberofproductionstoonesingleproduct
ion, namely the Cs
+ ion, which is measurable with high
specificityandhighsignalintensity.Itisofutmostimport-
ancetohaveahighlyspecificanalyticalmethodwithhigh
accuracy and precision for use as an intended reference
measurement procedure. The specificity of current LC-
MS/MSmethodsshouldbeimprovedbychromatographic
separation [9]. In the method presented here, all four
immunosuppressive drugs are fully separated. Different
internal standards listed in the text have been used for
the quantification of the four immunosuppressive drugs.
The best results were obtained using the corresponding
analogues,namelyascomycinfortacrolimus,32-desmeth-
oxy-rapamycinforsirolimusandeverolimusandcyclospo-
rinDforcyclosporinA.Thishasbeendiscussedelsewhere
by Vogeser et al [4].
A baseline separation of cyclosporin D from cyclosporin
Ahasbeenrealized,aswellastheseparationofsirolimus
from 32-desmethoxy-rapamycin. If needed, separation
ofeverolimusfromtheinternalstandard32-desmethoxy-
rapamycin or tacrolimus from the internal standard
ascomycin can be made by slight modifications of the
ternary gradient profile.
Untilnow,therearenopurereferencematerialsavailable
for the immunosuppressive agents. All analytes used
have been extracted from biological sources and contain
sodium and potassium ions (see Figure 2) which can be
removed by chromatographic separation so that the
presence of Na
+ and K
+ adducts was less than 2%.
The high throughput routine methods which have been
publishedfordeterminationofimmunosuppressivedrugs
donotseparatethedifferentimmunosuppressiveagents
chromatographically. As a result, the routine methods
currently in use are not suitable for setting target values
in EQAS. They have limited specificity [4] and are prone
to mass interferences [5]. In patient samples problems
may occur during quantification, due to the presence of
metabolites.Atleast13metaboliteshavebeendescribed
for cyclosporin A [10]. The metabolites are usually more
hydrophilic than the parent substance, due to hydroxyla-
tion, and can be separated by modifying the ternary
gradient system used here.
For optimal quantification it is desirable to have stable
isotope labelled analytes as internal standards [11]. Un-
fortunately, at present there are no commercial sources
forisotopicallylabelledimmunosuppressiveagents.When
stable-labelledcompoundsbecomeavailablethemethod
presented here can be developed into a reference
measurement procedure for immunosuppressive drugs.
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